Pasithea Therapeutics Stock Forward View - Simple Exponential Smoothing
| KTTA Stock | USD 0.86 0.01 1.18% |
Pasithea Stock outlook is based on your current time horizon. Investors can use this forecasting interface to forecast Pasithea Therapeutics stock prices and determine the direction of Pasithea Therapeutics Corp's future trends based on various well-known forecasting models. We recommend always using this module together with an analysis of Pasithea Therapeutics' historical fundamentals, such as revenue growth or operating cash flow patterns.
At this time, the RSI of Pasithea Therapeutics' share price is approaching 46. This indicates that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Pasithea Therapeutics, making its price go up or down. Momentum 46
Impartial
Oversold | Overbought |
Wall Street Target Price 3 | Quarterly Revenue Growth 14.981 |
Using Pasithea Therapeutics hype-based prediction, you can estimate the value of Pasithea Therapeutics Corp from the perspective of Pasithea Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Pasithea Relative Strength Index
The Simple Exponential Smoothing forecasted value of Pasithea Therapeutics Corp on the next trading day is expected to be 0.86 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 3.29.Pasithea Therapeutics Hype to Price Pattern
Investor biases related to Pasithea Therapeutics' public news can be used to forecast risks associated with an investment in Pasithea. The trend in average sentiment can be used to explain how an investor holding Pasithea can time the market purely based on public headlines and social activities around Pasithea Therapeutics Corp. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Pasithea Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Pasithea Therapeutics.
The Simple Exponential Smoothing forecasted value of Pasithea Therapeutics Corp on the next trading day is expected to be 0.86 with a mean absolute deviation of 0.05 and the sum of the absolute errors of 3.29. Pasithea Therapeutics after-hype prediction price | USD 0.87 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Pasithea Therapeutics to cross-verify your projections. Pasithea Therapeutics Additional Predictive Modules
Most predictive techniques to examine Pasithea price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pasithea using various technical indicators. When you analyze Pasithea charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Pasithea Therapeutics Simple Exponential Smoothing Price Forecast For the 2nd of February
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Pasithea Therapeutics Corp on the next trading day is expected to be 0.86 with a mean absolute deviation of 0.05, mean absolute percentage error of 0.01, and the sum of the absolute errors of 3.29.Please note that although there have been many attempts to predict Pasithea Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Pasithea Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Pasithea Therapeutics Stock Forecast Pattern
| Backtest Pasithea Therapeutics | Pasithea Therapeutics Price Prediction | Buy or Sell Advice |
Pasithea Therapeutics Forecasted Value
In the context of forecasting Pasithea Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Pasithea Therapeutics' downside and upside margins for the forecasting period are 0.01 and 19.22, respectively. We have considered Pasithea Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Pasithea Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Pasithea Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 111.8883 |
| Bias | Arithmetic mean of the errors | -0.0015 |
| MAD | Mean absolute deviation | 0.0548 |
| MAPE | Mean absolute percentage error | 0.0658 |
| SAE | Sum of the absolute errors | 3.29 |
Predictive Modules for Pasithea Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Pasithea Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pasithea Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Pasithea Therapeutics After-Hype Price Density Analysis
As far as predicting the price of Pasithea Therapeutics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pasithea Therapeutics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Pasithea Therapeutics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Pasithea Therapeutics Estimiated After-Hype Price Volatility
In the context of predicting Pasithea Therapeutics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pasithea Therapeutics' historical news coverage. Pasithea Therapeutics' after-hype downside and upside margins for the prediction period are 0.04 and 19.23, respectively. We have considered Pasithea Therapeutics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Pasithea Therapeutics is out of control at this time. Analysis and calculation of next after-hype price of Pasithea Therapeutics is based on 3 months time horizon.
Pasithea Therapeutics Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Pasithea Therapeutics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pasithea Therapeutics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pasithea Therapeutics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
1.26 | 18.36 | 0.01 | 0.08 | 10 Events / Month | 6 Events / Month | In about 10 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.86 | 0.87 | 1.16 |
|
Pasithea Therapeutics Hype Timeline
Pasithea Therapeutics is now traded for 0.86. The entity has historical hype elasticity of 0.01, and average elasticity to hype of competition of -0.08. Pasithea is anticipated to increase in value after the next headline, with the price projected to jump to 0.87 or above. The average volatility of media hype impact on the company the price is over 100%. The price jump on the next news is projected to be 1.16%, whereas the daily expected return is now at 1.26%. The volatility of related hype on Pasithea Therapeutics is about 30600.0%, with the expected price after the next announcement by competition of 0.78. Net Loss for the year was (13.9 M) with loss before overhead, payroll, taxes, and interest of (2.21 K). Given the investment horizon of 90 days the next anticipated press release will be in about 10 days. Check out Historical Fundamental Analysis of Pasithea Therapeutics to cross-verify your projections.Pasithea Therapeutics Related Hype Analysis
Having access to credible news sources related to Pasithea Therapeutics' direct competition is more important than ever and may enhance your ability to predict Pasithea Therapeutics' future price movements. Getting to know how Pasithea Therapeutics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pasithea Therapeutics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| QNRX | Quoin Pharmaceuticals Ltd | (0.40) | 9 per month | 0.00 | (0.04) | 18.69 | (11.19) | 77.47 | |
| IBO | Impact BioMedical | 0.02 | 9 per month | 0.00 | (0.02) | 8.00 | (7.41) | 61.57 | |
| KALA | Kala Pharmaceuticals | 0.04 | 8 per month | 0.00 | (0.03) | 12.28 | (10.77) | 59.48 | |
| AIM | AIM ImmunoTech | 0.01 | 11 per month | 0.00 | (0.20) | 7.69 | (10.32) | 29.72 | |
| TCRT | Alaunos Therapeutics | (0.26) | 7 per month | 5.52 | (0) | 9.61 | (10.55) | 24.31 | |
| VYNE | Vyne Therapeutics | (0.01) | 9 per month | 2.39 | 0.12 | 5.71 | (5.26) | 55.08 | |
| VIVS | VivoSim Labs | 0.01 | 9 per month | 4.70 | 0.07 | 7.22 | (8.95) | 42.16 | |
| CYCN | Cyclerion Therapeutics | (0.02) | 5 per month | 0.00 | (0.06) | 11.11 | (10.56) | 55.81 | |
| PLRZ | Polyrizon Ltd Ordinary | (0.28) | 9 per month | 6.54 | 0.11 | 11.50 | (14.22) | 149.99 | |
| NBY | NovaBay Pharmaceuticals | 0.29 | 8 per month | 13.27 | 0.12 | 33.70 | (24.76) | 158.53 |
Other Forecasting Options for Pasithea Therapeutics
For every potential investor in Pasithea, whether a beginner or expert, Pasithea Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Pasithea Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Pasithea. Basic forecasting techniques help filter out the noise by identifying Pasithea Therapeutics' price trends.Pasithea Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Pasithea Therapeutics stock to make a market-neutral strategy. Peer analysis of Pasithea Therapeutics could also be used in its relative valuation, which is a method of valuing Pasithea Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Pasithea Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Pasithea Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Pasithea Therapeutics shares will generate the highest return on investment. By undertsting and applying Pasithea Therapeutics stock market strength indicators, traders can identify Pasithea Therapeutics Corp entry and exit signals to maximize returns.
Pasithea Therapeutics Risk Indicators
The analysis of Pasithea Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Pasithea Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting pasithea stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 7.75 | |||
| Semi Deviation | 7.46 | |||
| Standard Deviation | 17.9 | |||
| Variance | 320.42 | |||
| Downside Variance | 91.78 | |||
| Semi Variance | 55.69 | |||
| Expected Short fall | (11.96) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Pasithea Therapeutics
The number of cover stories for Pasithea Therapeutics depends on current market conditions and Pasithea Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pasithea Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pasithea Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Pasithea Therapeutics Short Properties
Pasithea Therapeutics' future price predictability will typically decrease when Pasithea Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pasithea Therapeutics Corp often depends not only on the future outlook of the potential Pasithea Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pasithea Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 1.1 M | |
| Cash And Short Term Investments | 6.9 M |
Check out Historical Fundamental Analysis of Pasithea Therapeutics to cross-verify your projections. You can also try the Bond Analysis module to evaluate and analyze corporate bonds as a potential investment for your portfolios..
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pasithea Therapeutics. Expected growth trajectory for Pasithea significantly influences the price investors are willing to assign. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Pasithea Therapeutics assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (4.43) | Revenue Per Share | Quarterly Revenue Growth 14.981 | Return On Assets | Return On Equity |
The market value of Pasithea Therapeutics is measured differently than its book value, which is the value of Pasithea that is recorded on the company's balance sheet. Investors also form their own opinion of Pasithea Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Pasithea Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pasithea Therapeutics' market value can be influenced by many factors that don't directly affect Pasithea Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Pasithea Therapeutics' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Pasithea Therapeutics represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Pasithea Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.